The Impact of Medicare Bundled Payments

Status Completed

Clinical Trial Summary

Bundled payments (BP) are a key part of Medicare's shift away from the traditional fee-for-service (FFS) payment model. The investigators propose to study a nationwide randomized-controlled trial (RCT) of bundled payments for knee and hip replacements that was designed and implemented by CMS and launched in April 2016. Randomization was conducted at the Metropolitan Statistical Area (MSA) level with 67 MSAs and about 800 hospitals assigned to the treatment group. The investigators will examine the impact of bundled payments on Medicare spending, utilization, and quality. Study findings should be directly relevant for the design of payments for knee and hip replacements, two common and expensive medical procedures. Average impacts, as well as variation in impact across types of providers and markets may also shed light on economic mechanisms, which should be relevant for bundled payment initiatives under consideration for other medical services.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Arthroplasty, Replacement

Clinical Trial Details

NCT number	NCT03407885
Study type	Interventional
Source	Abdul Latif Jameel Poverty Action Lab
Contact
Status	Completed
Phase	N/A
Start date	April 2016
Completion date	February 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02728661` - Patient-Centered Weight Loss Program for Knee Replacement Patients	Phase 1/Phase 2
Recruiting	`NCT04080401` - Effectiveness of a Novel Gaming System on Post-operative Rehabilitation Outcomes After Total Knee Arthroplasty	N/A
Completed	`NCT02648958` - Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations	N/A
Completed	`NCT00846807` - Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery	N/A
Completed	`NCT04372173` - An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty
Recruiting	`NCT01909375` - American Joint Replacement Registry
Terminated	`NCT01153698` - Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
Completed	`NCT01184989` - Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate	Phase 4
Active, not recruiting	`NCT00114036` - Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE)	N/A
Completed	`NCT01857349` - Efficacy of Surgical Preparation Solutions in Knee Surgery	N/A
Completed	`NCT00847301` - Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery	N/A
Recruiting	`NCT04697004` - SMR Stemless Reverse vs SMR Reverse Shoulder System	N/A
Completed	`NCT03158623` - Wound Additives in Primary Total Joint Athroplasty	Phase 3